Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01571245 · ClinicalTrials.gov registry record

Predicting Treatment Response Using Psychophysiologic Reactivity Measures

A clinical trial, sponsored by Central Arkansas Veterans Healthcare System.

Completed
Registry status
9
Enrollment target

NCT01571245 is a clinical trial that has completed, run by Central Arkansas Veterans Healthcare System. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01571245 has completed, sponsored by Central Arkansas Veterans Healthcare System.

COMPLETED
Registry status
9 participants
Enrollment target

Study Summary

Objective psychophysiologic reactivity data may be useful for predicting post-traumatic stress disorder (PTSD) treatment response. Given the variety of PTSD treatments and the lack of a clearly superior treatment, a reliable and valid approach to predicting treatment response is needed. Specific Aims: 1). Evaluate the clinical utility of psychophysiologic reactivity measures to predict overall PTSD symptom response among OEF/OIF/OND (Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn) veterans receiving treatment for PTSD. 2). Evaluate the clinical utility of psychophysiologic reactivity measures to predict psychosocial functioning and health-related quality of life (HRQoL) response among OEF/OIF/OND veterans in treatment for PTSD. Exploratory). Develop psychophysiologic, neuropsychological, and/or self-report models to predict PTSD symptom response to pharmacotherapy, psychotherapy, and combined pharmacotherapy/psychotherapy. The investigators will divide psychophysiologic reactivity predictors into two groups: heart rate variability and attentional bias (eye gaze tracking and modified Stroop). The investigators will collect observational and longitudinal data from a treatment-seeking sample of 50 OEF/OIF/OND veterans with PTSD recruited from the Central Arkansas Veterans Healthcare System (CAVHS) Mental Health Clinics.

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2012-04
Est. Completion 2015-12

What the Registry Record Tells You About NCT01571245

The ClinicalTrials.gov registry entry for NCT01571245 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Central Arkansas Veterans Healthcare System, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01571245 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01571245 about?

NCT01571245 is a clinical study titled "Predicting Treatment Response Using Psychophysiologic Reactivity Measures". Objective psychophysiologic reactivity data may be useful for predicting post-traumatic stress disorder (PTSD) treatment response. Given the variety of PTSD treatments and the lack of a clearly superior treatment, a reliable and valid approach to predicting treatment response is needed. Specific Ai...

What is the current status of trial NCT01571245?

This trial is currently completed. The enrollment target is 9 participants. The study started on 2012-04. Estimated completion is 2015-12.

Who is sponsoring clinical trial NCT01571245?

This trial is sponsored by Central Arkansas Veterans Healthcare System, which has 9 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.